Van Berkom & Associates’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,176,729
| Closed | -$24.9M | – | 62 |
|
|
2020
Q4 | $24.9M | Sell |
2,176,729
-713,016
| -25% | -$8.12M | 0.57% | 45 |
|
|
2020
Q3 | $19.9M | Buy |
2,889,745
+4,782
| +0.2% | +$31.4K | 0.58% | 44 |
|
|
2020
Q2 | $18.8M | Buy |
2,884,963
+21,286
| +0.7% | +$137K | 0.55% | 44 |
|
|
2020
Q1 | $18.9M | Buy |
2,863,677
+159,443
| +6% | +$1.39M | 0.68% | 43 |
|
|
2019
Q4 | $28M | Buy |
2,704,234
+5,185
| +0.2% | +$44.3K | 0.76% | 46 |
|
|
2019
Q3 | $17.1K | Buy |
2,699,049
+42,039
| +2% | +$313K | 0.42% | 48 |
|
|
2019
Q2 | $19.8M | Sell |
2,657,010
-32,158
| -1% | -$212K | 0.57% | 47 |
|
|
2019
Q1 | $16.5M | Sell |
2,689,168
-78,371
| -3% | -$908K | 0.52% | 47 |
|
|
2018
Q4 | $31.9M | Buy |
2,767,539
+264,667
| +11% | +$4.52M | 1.13% | 44 |
|
|
2018
Q3 | $54.2M | Sell |
2,502,872
-37,717
| -1% | -$714K | 1.54% | 39 |
|
|
2018
Q2 | $40.1M | Buy |
2,540,589
+34,611
| +1% | +$544K | 1.17% | 45 |
|
|
2018
Q1 | $47.2M | Sell |
2,505,978
-52,910
| -2% | -$1.04M | 1.43% | 40 |
|
|
2017
Q4 | $44.5M | Buy |
2,558,888
+367,025
| +17% | +$5.07M | 1.45% | 43 |
|
|
2017
Q3 | $32.8M | Buy |
2,191,863
+1,820,649
| +490% | +$28.6M | 1.18% | 45 |
|
|
2017
Q2 | $6.89M | Buy |
+371,214
| New | +$6.45M | 0.25% | 49 |
|
Van Berkom & Associates's ARA Position: Q1 2021 in Review
Van Berkom & Associates sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 2,176,729 shares — an estimated $24.9M sold.
Van Berkom & Associates first reported a position in ARA in Q2 2017 and held it in 15 quarters. The position peaked at $54.2M in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Van Berkom & Associates reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Van Berkom & Associates sold 2,176,729 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $24.9M.
- Van Berkom & Associates first reported a position in American Renal Associates Holdings, Inc in Q2 2017 and held it in 15 quarters.
- Van Berkom & Associates's American Renal Associates Holdings, Inc position peaked at $54.2M in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Van Berkom & Associates's 13F filing for Q1 2021, filed 14 May 2021.